Six Years for a Prescription Pad: Ruti Aga's Ban Is a Document Story, Not a Drug Story

The paperwork is what ends careers. On Thursday the Athletics Integrity Unit published its decision in the case of Ruti Aga, the Ethiopian marathoner who won Tokyo in 2026, and the number that will follow her is six years. The substance was methylprednisolone, a glucocorticoid used for joint inflammation. The reason the ban runs until roughly her 38th birthday is a prescription form signed by a family member, naming a clinic that does not exist, on a pad the clinic says it never issued.

I have read denial statements from a commentary position before. A syringe in Gold Coast taught me that recovery is a public performance. What those corridors never prepare you for is how small the paper is: one sheet, one stamp, one signature in the wrong hand.

Context

Aga's record is the record of a genuinely elite road runner. Second at Berlin in 2026 in 2:18:34. First at Tokyo in 2026 in 2:20:40. Three second-place finishes at World Marathon Majors, the commercial tier that pays appearance fees and sets the market rate for everyone below the world-record cohort. She is 32.

In March she won a half marathon in China. A sample from that race returned an adverse finding for methylprednisolone. The AIU provisionally suspended her on 10 September, and on Thursday the full sanction landed: two years for presence, four for tampering, six in total, counted from the provisional suspension.

The arithmetic is where the story sits. A presence violation for a specified substance, argued without proven intent, routinely lands at two years. Tampering carries four under the Code. Two plus four equals six means the panel accepted the standard presence sanction and then found the fabrication fully culpable. The forged document did not aggravate the doping charge; it added a charge of its own.

Core: the classification error that decided everything

Most reports called methylprednisolone a prohibited steroid and moved on. It is not a steroid in the anabolic sense. It is a glucocorticoid, WADA Prohibited List class S9, and under the current List S9 substances are prohibited in-competition only, by injection, oral or rectal routes. The patch notes arrived before the players did: when the 2026 List tightened around in-competition glucocorticoid injection, it built a strict-liability trap for exactly the population that takes therapeutic knee injections most, high-mileage marathoners.

That distinction carries the entire defence. An intra-articular injection for knee synovitis given weeks out from a race is legal. It becomes a violation only if residues are still detectable in-competition, and a road race's testing window opens at 23:59 the day before the start. Route, dose and timing were all arguable. A properly managed athlete with documented treatment and a therapeutic use exemption would have walked into that hearing with a case. Aga had the one defence that could have worked, and she replaced it with a document.

The document chain shows a medical structure that barely exists. The prescriber was a family member with no medical registration. The clinic named on the form did not exist. The prescriber's explanation, an old prescription pad from a former workplace, was disowned by that workplace. Three independent verification failures, each of which a competent team physician would have caught before the paper reached the AIU.

This is where the Chinese label-race circuit enters the ledger. For East African marathoners in the 2:18 to 2:22 band, those races are the income tier between Majors: start money, low race count, a result that keeps an agent's phone ringing. The same tier is now the AIU's highest-yield testing ground. The appearance-fee economy and the testing economy occupy the same start line, and the athletes between them are managed by entourages that are professional about flights and amateur about anti-doping paperwork. The enforcement frontier has shifted from detection to document verification. Tampering is no longer the rare second charge in this cluster of cases; it is the recurring one.

What survives is specific. Her 2026 Tokyo title and the Major podium finishes stand, because the violation is anchored to a race in a later year and earlier results are not automatically annulled without a finding of earlier use. Her result and prize money from the March race are almost certainly void, with ranking points from that date forward gone. The career record survives; the commercial record does not.

Contrarian: the disproportion argument, and its limit

Six years for a glucocorticoid with no established endurance benefit is a longer ban than some athletes have served for EPO. The comparison will be made, and it will be made in East Africa, where the AIU's road-running caseload is concentrated and where the language and translation conditions of investigative interviews are a standing grievance.

The comparison is also incomplete. She was not sanctioned six years for the injection. She was sanctioned two years for the injection and four for the answer she gave when asked about it. Every athlete in that position faces the same choice, and culpability lives in the four.

The sharper observation runs to the root cause, and it is uncomfortable for everyone. The knee came first. Chronic knee pathology is a known failure mode in high-volume marathoners, and an injured 32-year-old protecting appearance-fee income has a strong incentive to mask pain. Glucocorticoids are the cheapest tool for that. The forgery sits downstream of a governance gap, not upstream of it: a system that produces world-class runners without producing credentialed medical staff around them, then punishes the symptom with the full weight of the Code.

I will not build a martyr out of this. Grief without an accounting is nostalgia, and the accounting here is plain: no team physician, no TUE process, no verification. And a result we cannot even measure, because the statement gives no mark, no splits and no field strength for the March half marathon. Her win is a fact. Its quality is unknown, and any performance judgment built on it would be invention.

Takeaway

The appeal window runs about three weeks from the reasoned decision, and a finding built on documents is hard to overturn. What to watch is quieter: whether the March result is formally annulled with its prize money, whether the Ethiopian federation says anything at all, and whether anyone asks who advised the signature. A host is just a translator between the scoreboard and the story. Here the scoreboard is a filing cabinet, and the story is a woman who will be 38 when she is eligible again, in a country where 2:18 does not guarantee a lane.